{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:55:02Z","timestamp":1781711702569,"version":"3.54.5"},"reference-count":127,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Minister of Science"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Neurodegenerative disorders and epilepsy remain major clinical challenges, due to complex etiologies involving protein misfolding, excitotoxicity, metabolic dysregulation, and impaired cellular resilience. These unmet medical needs have stimulated interest in small-molecule modulators capable of targeting multiple pathogenic pathways. Cyclitols, a diverse family of inositol stereoisomers, play essential roles in cellular signaling and brain metabolism; among them, scyllo-inositol (SCI) has gained attention due to its distinct stereochemistry, capacity to cross the blood\u2013brain barrier, and emerging neuroactive properties. Current pharmacokinetic data indicate that SCI exhibits dose-dependent systemic exposure, and good penetration into the central nervous system. Moreover, its supplementation seems to be well-tolerated. In experimental studies both on animals and humans, SCI has been shown to modulate amyloid-\u03b2 aggregation, stabilize neuronal homeostatic pathways, and reduce network hyperexcitability, suggesting relevance for both neurodegenerative and epileptic phenotypes. Despite promising results, there is still a need for further analyses to define dosing, transporter involvement, and brain exposure thresholds. Collectively, the available data position SCI as a compelling candidate for translational development, warranting further investigation into its therapeutic window and disease-modifying potential across neurological disorders.<\/jats:p>","DOI":"10.3390\/nu18121955","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:11:22Z","timestamp":1781709082000},"page":"1955","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Scyllo-Inositol as a Neuroactive Agent: From Pharmacokinetics to Neuroprotective and Antiepileptic Effects"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6479-3263","authenticated-orcid":false,"given":"Karol","family":"Wi\u015bniewski","sequence":"first","affiliation":[{"name":"Students\u2019 Scientific Club of Pathophysiologists, Department of Human Physiology and Pathophysiology, School of Medicine, University of Warmia and Mazury, 10-082 Olsztyn, Poland"},{"name":"Department of Human Physiology and Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-085 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6577-7545","authenticated-orcid":false,"given":"Kamila","family":"Zglejc-Waszak","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Histology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-085 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Warzecha","sequence":"additional","affiliation":[{"name":"Students\u2019 Scientific Club of Pathophysiologists, Department of Human Physiology and Pathophysiology, School of Medicine, University of Warmia and Mazury, 10-082 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3401-2758","authenticated-orcid":false,"given":"Marcin","family":"Jozwik","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-045 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Thoene","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, School of Public Health, University of Warmia and Mazury in Olsztyn, 10-561 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0856-3644","authenticated-orcid":false,"given":"Joanna","family":"Wojtkiewicz","sequence":"additional","affiliation":[{"name":"Department of Human Physiology and Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-085 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/hup.1241","article-title":"Myo-inositol in the treatment of premenstrual dysphoric disorder","volume":"26","author":"Carlomagno","year":"2011","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Antonowski, T., Osowski, A., Lahuta, L., G\u00f3recki, R., Rynkiewicz, A., and Wojtkiewicz, J. (2019). Health-promoting properties of selected cyclitols for metabolic syndrome and diabetes. Nutrients, 11.","DOI":"10.3390\/nu11102314"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Gambero, A.J., Sanjuan, C., Serrano-Castro, P.J., Su\u00e1rez, J., and Rodr\u00edguez de Fonseca, F. (2020). The biomedical uses of Inositols: A nutraceutical approach to metabolic dysfunction in aging and neurodegenerative diseases. Biomedicines, 8.","DOI":"10.3390\/biomedicines8090295"},{"key":"ref_4","unstructured":"George, E.F., Hall, M.A., and Klerk, G.-J.D. (2008). The components of Plant Tissue Culture Media II: Organic additions, osmotic and ph effects, and support systems. Plant Propagation by Tissue Culture, Springer."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/jxb\/44.8.1351","article-title":"Carbohydrate metabolism in drought-stressed leaves of pigeonpea (Cajanus cajan)","volume":"44","author":"Keller","year":"1993","journal-title":"J. Exp. Bot."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/17425255.2016.1206887","article-title":"Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease","volume":"12","author":"Bizzarri","year":"2016","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-9452(99)00150-8","article-title":"Myo-inositol metabolism in plants","volume":"150","author":"Loewus","year":"2000","journal-title":"Plant Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF00951457","article-title":"Identification of ononitol and O-methyl-SCYLLO-inositol in pea root nodules","volume":"161","author":"Egsgaard","year":"1984","journal-title":"Planta"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"802","DOI":"10.2136\/sssaj2004.8020","article-title":"Identification of scyllo-inositol phosphates in soil by solution phosphorus-31 nuclear magnetic resonance spectroscopy","volume":"68","author":"Turner","year":"2004","journal-title":"Soil Sci. Soc. Am. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0021-9258(18)96198-3","article-title":"Biosynthesis of streptomycin","volume":"242","author":"Bruton","year":"1967","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1021\/cg060179a","article-title":"Polymorphism of Scyllo-inositol: Joining crystal structure prediction with experiment to elucidate the structures of two polymorphs","volume":"6","author":"Day","year":"2006","journal-title":"Cryst. Growth Des."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/S0968-0896(99)00183-2","article-title":"Synthesis of all possible regioisomers of Scyllo-inositol phosphate","volume":"7","author":"Chung","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/ejoc.200200572","article-title":"Stereoselective synthesis of myo-, neo-, l-chiro, d-chiro, allo-, scyllo-, and epi-inositol systems via conduritols prepared from p-benzoquinone","volume":"2003","author":"Podeschwa","year":"2003","journal-title":"Eur. J. Org. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ymben.2021.06.011","article-title":"Metabolic Engineering of corynebacterium glutamicum for production of Scyllo-Inositol, a drug candidate against alzheimer\u2019s disease","volume":"67","author":"Ramp","year":"2021","journal-title":"Metab. Eng."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1475-2859-10-69","article-title":"A cell factory of bacillus subtilis engineered for the simple bioconversion of myo-inositol to Scyllo-inositol, a potential therapeutic agent for alzheimer\u2019s disease","volume":"10","author":"Yamaoka","year":"2011","journal-title":"Microb. Cell Factories"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"18495","DOI":"10.1074\/jbc.M906994199","article-title":"Inositol stereoisomers stabilize an oligomeric aggregate of alzheimer amyloid \u03b2 peptide and inhibit A\u0392-induced toxicity","volume":"275","author":"McLaurin","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1074\/jbc.M113.501635","article-title":"Scyllo-inositol promotes robust mutant huntingtin protein degradation","volume":"289","author":"Lai","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbrc.2015.12.043","article-title":"A-synuclein aggregation, seeding and inhibition by Scyllo-Inositol","volume":"469","author":"Ibrahim","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Wi\u015bniewski, K., Antonowski, T., Juranek, J., Podlasz, P., and Wojtkiewicz, J. (2023). Antiepileptic properties of Scyllo-inositol on Pentylenetetrazol-induced seizures. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087598"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.seizure.2010.10.008","article-title":"Anticonvulsant activities of myo-inositol and Scyllo-inositol on pentylenetetrazol induced seizures","volume":"20","author":"Nozadze","year":"2011","journal-title":"Seizure"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/epi4.13061","article-title":"Preventing epileptogenesis by interaction between inositol isomers and proteins","volume":"10","author":"Tsverava","year":"2025","journal-title":"Epilepsia Open"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.0b013e3182309fa5","article-title":"A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate alzheimer disease","volume":"77","author":"Salloway","year":"2011","journal-title":"Neurology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"18514","DOI":"10.1039\/C5CP02690C","article-title":"Structures, stability and hydrogen bonding in inositol conformers","volume":"17","author":"Siddiqui","year":"2015","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref_24","unstructured":"(2025, December 22). Scyllo-Inositol. Available online: https:\/\/www.chemsrc.com\/en\/cas\/488-59-5_598751.html."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0008-6215(91)84034-C","article-title":"Determination of the activation energy and rate constants for the chair-to-chair interconversion of cis-inositol by N.M.R. spectroscopy","volume":"215","author":"Dill","year":"1991","journal-title":"Carbohydr. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1021\/ja00005a015","article-title":"Solvent effect on the anomeric equilibrium in D-glucose: A free energy simulation analysis","volume":"113","author":"Ha","year":"1991","journal-title":"J. Am. Chem. Soc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0065-2318(08)60264-4","article-title":"Structures and syntheses of aminoglycoside antibiotics","volume":"30","author":"Umezawa","year":"1974","journal-title":"Adv. Carbohydr. Chem. Biochem."},{"key":"ref_28","first-page":"259","article-title":"Chemistry of the amino sugars derived from antibiotic substances","volume":"18","author":"Dutcher","year":"1963","journal-title":"Adv. Carbohydr. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1039\/c1cc10643k","article-title":"\u201cInosaminoacids\u201d: Novel inositol\u2013amino acid hybrid structures accessed by microbial arene oxidation","volume":"47","author":"Pilgrim","year":"2011","journal-title":"Chem. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/nbm.1940060116","article-title":"Identification of scyllo-inositol in Proton NMR spectra of human brain in vivo","volume":"6","author":"Michaelis","year":"1993","journal-title":"NMR Biomed."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejogrb.2015.09.024","article-title":"Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in obstetrics and gynecology: The link between metabolic syndrome and PCOS","volume":"195","author":"Facchinetti","year":"2015","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.nu.06.070186.003023","article-title":"Metabolism and function of myo-inositol and inositol phospholipids","volume":"6","author":"Holub","year":"1986","journal-title":"Annu. Rev. Nutr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/anie.201502227","article-title":"The \u201cother\u201d Inositols and their phosphates: Synthesis, biology, and medicine (with recent advances inmyo-inositol chemistry)","volume":"55","author":"Thomas","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00234656","article-title":"Kinetics and specificity of the renal Na+\/myo-inositol cotransporter expressed in xenopus oocytes","volume":"143","author":"Hager","year":"1995","journal-title":"J. Membr. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"35219","DOI":"10.1074\/jbc.M204321200","article-title":"Identification of a novel Na+\/myo-inositol cotransporter","volume":"277","author":"Coady","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/bj1670229","article-title":"Free and lipid myo-inositol in tissues from rats with acute and less severe streptozotocin-induced diabetes","volume":"167","author":"Palmano","year":"1977","journal-title":"Biochem. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"11710","DOI":"10.1016\/S0021-9258(19)70191-4","article-title":"Stereochemistry of the myo-inositol-1-phosphate synthase reaction","volume":"255","author":"Loewus","year":"1980","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.biochi.2013.05.011","article-title":"Potential role and therapeutic interests of myo-inositol in metabolic diseases","volume":"95","author":"Croze","year":"2013","journal-title":"Biochimie"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Fenili, D., Weng, Y.-Q., Aubert, I., Nitz, M., and McLaurin, J. (2011). Sodium\/myo-inositol transporters: Substrate transport requirements and regional brain expression in the TGCRND8 mouse model of amyloid pathology. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024032"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neuropharm.2010.03.011","article-title":"Detection of increased Scyllo-inositol in brain with magnetic resonance spectroscopy after dietary supplementation in alzheimer\u2019s disease mouse models","volume":"59","author":"Choi","year":"2010","journal-title":"Neuropharmacology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00109-007-0156-7","article-title":"Properties of scyllo\u2013inositol as a therapeutic treatment of ad-like pathology","volume":"85","author":"Fenili","year":"2007","journal-title":"J. Mol. Med."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Wi\u015bniewski, K., Zglejc-Waszak, K., Antonowski, T., Szablinska-Piernik, J., Juskiewicz, J., Lahuta, L., Jozwik, M., and Wojtkiewicz, J. (2025). Analysis of scyllo-inositol in a Wistar rat animal model\u2014A preliminary study. Pharmaceuticals, 18.","DOI":"10.3390\/ph18070954"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1021\/jf305322t","article-title":"Detection of orally administered inositol stereoisomers in mouse blood plasma and their effects on translocation of glucose transporter 4 in skeletal muscle cells","volume":"61","author":"Yamashita","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/cpdd.14","article-title":"Pharmacokinetic profile of orally administered scyllo-inositol (ELND005) in plasma, cerebrospinal fluid and brain, and corresponding effect on amyloid-beta in healthy subjects","volume":"2","author":"Liang","year":"2013","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"a028035","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Lamptey, R.N.L., Chaulagain, B., Trivedi, R., Gothwal, A., Layek, B., and Singh, J. (2022). A review of the common neurodegenerative disorders: Current therapeutic approaches and the potential role of Nanotherapeutics. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031851"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"102357","DOI":"10.1016\/j.arr.2024.102357","article-title":"Neurodegenerative disorders: Mechanisms of degeneration and therapeutic approaches with their clinical relevance","volume":"99","author":"Gadhave","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12264-022-00905-x","article-title":"Magnetic Resonance Imaging Studies of neurodegenerative disease: From methods to translational research","volume":"39","author":"Huang","year":"2022","journal-title":"Neurosci. Bull."},{"key":"ref_49","first-page":"e12334","article-title":"Alzheimer\u2019s disease diagnosis and management: Perspectives from around the world","volume":"14","author":"Kerwin","year":"2022","journal-title":"Alzheimer\u2019s Dement. Diagn. Assess. Dis. Monit."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s40120-023-00504-6","article-title":"A systematic review of Clinical Practice Guidelines for alzheimer\u2019s disease and strategies for future advancements","volume":"12","author":"Phan","year":"2023","journal-title":"Neurol. Ther."},{"key":"ref_51","unstructured":"Alzheimer\u2019s Disease International (2025, December 24). Adi\u2014World Alzheimer Report 2019. Available online: https:\/\/www.alzint.org\/resource\/world-alzheimer-report-2019\/."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3233\/JAD-210493","article-title":"Model-based projection of dementia prevalence in China and worldwide: 2020\u20132050","volume":"82","author":"Li","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/pro.2524","article-title":"A brief overview of amyloids and alzheimer\u2019s disease","volume":"23","author":"Ow","year":"2014","journal-title":"Protein Sci."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Breijyeh, Z., and Karaman, R. (2020). Comprehensive review on alzheimer\u2019s disease: Causes and treatment. Molecules, 25.","DOI":"10.3390\/molecules25245789"},{"key":"ref_55","unstructured":"World Health Organization (2025, December 26). Risk Reduction of Cognitive Decline and Dementia: WHO Guidelines. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789241550543."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1021\/acschemneuro.5c00493","article-title":"Donepezil and memantine derivatives for dual-function and prodrug applications in alzheimer\u2019s disease","volume":"16","author":"Terpstra","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"ref_57","unstructured":"(2025, December 26). Cholinesterase. Available online: https:\/\/www.sciencedirect.com\/topics\/biochemistry-genetics-and-molecular-biology\/cholinesterase."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1503\/cmaj.081103","article-title":"Diagnosis and treatment of dementia: 5. nonpharmacologic and pharmacologic therapy for mild to moderate dementia","volume":"179","author":"Hogan","year":"2008","journal-title":"Can. Med. Assoc. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"26482","DOI":"10.1074\/jbc.271.43.26482","article-title":"Membrane disruption by alzheimer \u03b2-amyloid peptides mediated through specific binding to either phospholipids or gangliosides","volume":"271","author":"McLaurin","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ana.21051","article-title":"Orally available compound prevents deficits in memory caused by the alzheimer amyloid-\u03b2 oligomers","volume":"60","author":"Townsend","year":"2006","journal-title":"Ann. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nm1423","article-title":"Cyclohexanehexol inhibitors of A\u0392 aggregation prevent and reverse alzheimer phenotype in a mouse model","volume":"12","author":"McLaurin","year":"2006","journal-title":"Nat. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"P425","DOI":"10.1016\/j.jalz.2009.04.950","article-title":"P3-279: Scyllo-inositol (ELND005) ameliorates amyloid pathology in an aggressive mouse model of alzheimer\u2019s disease","volume":"5","author":"DaSilva","year":"2009","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.expneurol.2013.10.001","article-title":"Combination therapy in a transgenic model of alzheimer\u2019s disease","volume":"250","author":"Aytan","year":"2013","journal-title":"Exp. Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1242\/dmm.007963","article-title":"Development and validation of a yeast high-throughput screen for inhibitors of a\u03b242 oligomerization","volume":"4","author":"Park","year":"2011","journal-title":"Dis. Models Mech."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3233\/JAD-2011-102022","article-title":"High Throughput Monitoring of amyloid-\u039242 assembly into soluble oligomers achieved by sensitive conformation state-dependent immunoassays","volume":"25","author":"Zhao","year":"2011","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1038\/ncomms6857","article-title":"Small molecule-mediated stabilization of vesicle-associated helical \u03b1-synuclein inhibits pathogenic misfolding and aggregation","volume":"5","author":"Eisbach","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"McFarland, N.R., Dimant, H., Kibuuka, L., Ebrahimi-Fakhari, D., Desjardins, C.A., Danzer, K.M., Danzer, M., Fan, Z., Schwarzschild, M.A., and Hirst, W. (2014). Chronic treatment with novel small molecule HSP90 inhibitors rescues striatal dopamine levels but not \u03b1-synuclein-induced neuronal cell loss. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0086048"},{"key":"ref_68","first-page":"a024091","article-title":"Cell Biology and pathophysiology of \u03b1-synuclein","volume":"8","author":"Sharma","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin. Geriatr. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ana.25441","article-title":"Concordance for parkinson\u2019s disease in twins: A 20-Year update","volume":"85","author":"Goldman","year":"2019","journal-title":"Ann. Neurol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/mds.27193","article-title":"Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature","volume":"32","author":"Schneider","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tins.2018.09.007","article-title":"Triggers, facilitators, and aggravators: Redefining parkinson\u2019s disease pathogenesis","volume":"42","author":"Johnson","year":"2019","journal-title":"Trends Neurosci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1073\/pnas.2628045100","article-title":"A cell-based assay for aggregation inhibitors as therapeutics of poly-glutamine-repeat disease and validation in Drosophila","volume":"100","author":"Apostol","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJMra022308","article-title":"Epilepsy","volume":"349","author":"Chang","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1528-1167.2010.02828.x","article-title":"Alterations in synaptic function in epilepsy","volume":"51","author":"Bernard","year":"2010","journal-title":"Epilepsia"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1126\/science.3037700","article-title":"Cellular mechanisms of epilepsy: A status report","volume":"237","author":"Dichter","year":"1987","journal-title":"Science"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrn3482","article-title":"Mechanisms of epileptogenesis: A convergence on neural circuit dysfunction","volume":"14","author":"Goldberg","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1055\/s-0031-1299789","article-title":"Genetics of epilepsy","volume":"31","author":"Pandolfo","year":"2011","journal-title":"Semin. Neurol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11910-007-0053-z","article-title":"The Neurobiology of Epilepsy and aging","volume":"7","author":"Scharfman","year":"2007","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_81","unstructured":"Huguenard, J., McCormick, D.A., and Shepherd, G.M. (1994). Electrophysiology of the Neuron: An Interactive Tutorial, Oxford University Press."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0920-1211(92)90034-Q","article-title":"Contribution of Na+, K+-Atpase to focal epilepsy: A brief review","volume":"12","author":"Grisar","year":"1992","journal-title":"Epilepsy Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/1073858402008003011","article-title":"Ion Regulation in the brain: Implications for pathophysiology","volume":"8","author":"Somjen","year":"2002","journal-title":"Neuroscientist"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.molmed.2005.10.007","article-title":"Do astrocytes contribute to excitation underlying seizures?","volume":"11","author":"Fellin","year":"2005","journal-title":"Trends Mol. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/978-1-4757-6376-8_9","article-title":"Gap junctions, fast oscillations and the initiation of seizures","volume":"548","author":"Traub","year":"2004","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1002\/ana.410160711","article-title":"The synaptic nature of the paroxysmal depolarizing shift in hippocampal neurons","volume":"16","author":"Johnston","year":"1984","journal-title":"Ann. Neurol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.expneurol.2013.04.004","article-title":"Neurostimulation in the treatment of epilepsy","volume":"244","author":"Bergey","year":"2013","journal-title":"Exp. Neurol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"123729","DOI":"10.1016\/j.wneu.2025.123729","article-title":"Comparative efficacy of surgical strategies for drug-resistant epilepsy: A systematic review and meta-analysis","volume":"195","author":"Dong","year":"2025","journal-title":"World Neurosurg."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1034\/j.1601-183X.2003.00038.x","article-title":"Can zebrafish be used as a model to study the neurodevelopmental causes of autism?","volume":"2","author":"Tropepe","year":"2003","journal-title":"Genes Brain Behav."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.brainres.2004.03.027","article-title":"Connections of the ventral telencephalon (subpallium) in the zebrafish (Danio rerio)","volume":"1011","author":"Rink","year":"2004","journal-title":"Brain Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1601-183X.2003.00053.x","article-title":"Linking genes to brain, behavior and neurological diseases: What can we learn from zebrafish?","volume":"3","author":"Guo","year":"2003","journal-title":"Genes Brain Behav."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2147\/NDT.S2056","article-title":"Zebrafish: An in vivo model for the study of neurological diseases","volume":"4","author":"Best","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/0024-3205(84)90159-0","article-title":"Convulsant potencies of tetrazoles are highly correlated with actions on GABA\/benzodiazepine\/picrotoxin receptor complexes in brain","volume":"35","author":"Squires","year":"1984","journal-title":"Life Sci."},{"key":"ref_95","first-page":"237","article-title":"Spike morphology in PTZ-induced generalized and cobalt-induced partial experimental epilepsy","volume":"11","author":"Tourov","year":"1996","journal-title":"Funct. Neurol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Afrikanova, T., Serruys, A.-S.K., Buenafe, O.E.M., Clinckers, R., Smolders, I., de Witte, P.A., Crawford, A.D., and Esguerra, C.V. (2013). Validation of the zebrafish Pentylenetetrazol seizure model: Locomotor versus electrographic responses to Antiepileptic Drugs. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0054166"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eplepsyres.2007.03.015","article-title":"Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants","volume":"75","author":"Berghmans","year":"2007","journal-title":"Epilepsy Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"dmm049080","DOI":"10.1242\/dmm.049080","article-title":"A zebrafish-centric approach to antiepileptic drug development","volume":"14","author":"Baraban","year":"2021","journal-title":"Dis. Models Mech."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.nbd.2017.08.005","article-title":"Recent findings on the physiological function of DJ-1: Beyond parkinson\u2019s disease","volume":"108","author":"Biosa","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"564534","DOI":"10.1155\/2013\/564534","article-title":"Neuroprotective function of 14-3-3 proteins in neurodegeneration","volume":"2013","author":"Shimada","year":"2013","journal-title":"BioMed Res. Int."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Desprez, F., Ung, D.C., Vourc\u2019h, P., Jeanne, M., and Laumonnier, F. (2023). Contribution of the dihydropyrimidinase-like proteins family in synaptic physiology and in neurodevelopmental disorders. Front. Neurosci., 17.","DOI":"10.3389\/fnins.2023.1154446"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF02246978","article-title":"Restoration of brainmyo-inositol levels in rats increases latency to lithium-pilocarpine seizures","volume":"110","author":"Kofman","year":"1993","journal-title":"Psychopharmacology"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10517-007-0016-z","article-title":"Effect of myo-inositol on convulsions induced by pentylenetetrazole and Kainic acid in rats","volume":"143","author":"Solomonia","year":"2007","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/WNR.0000000000001341","article-title":"Concentration- and time-dependent effects of myo-inositol on evoked epileptic afterdischarge in the hippocampus in vivo","volume":"30","author":"Gamkrelidze","year":"2019","journal-title":"NeuroReport"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Kandashvili, M., Gamkrelidze, G., Tsverava, L., Lordkipanidze, T., Lepsveridze, E., Lagani, V., Burjanadze, M., Dashniani, M., Kokaia, M., and Solomonia, R. (2022). Myo-inositol limits kainic acid-induced epileptogenesis in rats. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031198"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4518160","DOI":"10.1155\/2019\/4518160","article-title":"Long-term effects of myoinositol on behavioural seizures and biochemical changes evoked by Kainic acid induced epileptogenesis","volume":"2019","author":"Tsverava","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1471-4159.2002.01041.x","article-title":"Inositol and higher inositol phosphates in neural tissues: Homeostasis, metabolism and functional significance","volume":"82","author":"Fisher","year":"2002","journal-title":"J. Neurochem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1021\/bi00842a040","article-title":"Identification of myo-inosose-2 and Scyllo-inositol in mammalian tissues","volume":"7","author":"Sherman","year":"1968","journal-title":"Biochemistry"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/0005-2736(74)90028-5","article-title":"Properties of Scyllitol transport in rat kidney slices","volume":"373","author":"Takenawa","year":"1974","journal-title":"Biochim. Biophys. Acta BBA Biomembr."},{"key":"ref_110","first-page":"185","article-title":"Purification and identification of components of the Aquilegia vulgaris extract fraction exhibiting anti-epileptic activity","volume":"4","author":"Solomonia","year":"2004","journal-title":"J. Biol. Phys. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10571-012-9877-4","article-title":"Myo-inositol treatment and GABA-A receptor subunit changes after kainate-induced status epilepticus","volume":"33","author":"Solomonia","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1152\/jn.00421.2005","article-title":"An extrasynaptic GABAA receptor mediates tonic inhibition in thalamic VB neurons","volume":"94","author":"Jia","year":"2005","journal-title":"J. Neurophysiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1124\/mol.104.007385","article-title":"Cultured hippocampal pyramidal neurons express two kinds of GABAA receptors","volume":"67","author":"Mangan","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature05185","article-title":"Phosphoinositides in cell regulation and membrane dynamics","volume":"443","year":"2006","journal-title":"Nature"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2006.03913.x","article-title":"The glutamate\/GABA-glutamine cycle: Aspects of transport, neurotransmitter homeostasis and ammonia transfer","volume":"98","author":"Bak","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"H\u00e9ja, L., Nyitrai, G., K\u00e9kesi, O., Dobolyi, \u00c1., Szab\u00f3, P., Fi\u00e1th, R., Ulbert, I., P\u00e1l-Szenthe, B., Palkovits, M., and Kardos, J. (2012). Astrocytes convert network excitation to tonic inhibition of neurons. BMC Biol., 10.","DOI":"10.1186\/1741-7007-10-26"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"a022863","DOI":"10.1101\/cshperspect.a022863","article-title":"Glutamatergic mechanisms associated with seizures and epilepsy","volume":"5","author":"White","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: Implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"C990","DOI":"10.1152\/ajpcell.1996.270.4.C990","article-title":"Osmotic regulation of Na-myo-inositol cotransporter mrna level and activity in endothelial and Neural Cells","volume":"270","author":"Wiese","year":"1996","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"C784","DOI":"10.1152\/ajpcell.1991.260.4.C784","article-title":"Upregulation of inositol transport mediates inositol accumulation in hyperosmolar brain cells","volume":"260","author":"Strange","year":"1991","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0169-328X(99)00127-8","article-title":"Kainic acid-induced seizure upregulates Na+\/myo-inositol cotransporter mrna in rat brain","volume":"70","author":"Nonaka","year":"1999","journal-title":"Mol. Brain Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"E3290","DOI":"10.1073\/pnas.1606348113","article-title":"Osmoregulatory inositol transporter SMIT1 modulates electrical activity by adjusting PI(4,5)P2 levels","volume":"113","author":"Dai","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Derkaczew, M., Martyniuk, P., Osowski, A., and Wojtkiewicz, J. (2023). Cyclitols: From basic understanding to their association with neurodegeneration. Nutrients, 15.","DOI":"10.3390\/nu15092029"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11096-018-0749-y","article-title":"Patients\u2019 experiences with multidose drug dispensing: A cross sectional study","volume":"41","author":"Mertens","year":"2018","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"6866","DOI":"10.1002\/anie.201310006","article-title":"Peptide nanotubes","volume":"53","author":"Hamley","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3233\/JAD-160965","article-title":"A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia","volume":"58","author":"Rafii","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mrm.1910390220","article-title":"Identification of a high concentration of scyllo-inositol in the brain of a healthy human subject using 1H- and 13C-NMR","volume":"39","author":"Seaquist","year":"1998","journal-title":"Magn. Reson. Med."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/12\/1955\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:27:47Z","timestamp":1781710067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/12\/1955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":127,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["nu18121955"],"URL":"https:\/\/doi.org\/10.3390\/nu18121955","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]}}}